Immatics (IMTX) Cash from Operations (2019 - 2025)
Immatics (IMTX) posted Cash from Operations of 68288612.79 for Q4 2025, down 30.68% sequentially from 52256762.58 in Q3 2025, and down 9.28% YoY from 75277519.82 in Q4 2024.
Immatics (IMTX) Cash from Operations (2019 - 2025) Analysis & Trends
Immatics has reported Cash from Operations for 7 years, with the latest figure at 68288612.79 in Q4 2025.
- Quarterly Cash from Operations fell 9.28% year-over-year to 68288612.79 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 200734820.13 (down 17.58% YoY) and the FY2025 annual result came in at 199554031.22, down 16.67% from the prior year.
- Cash from Operations fell to 68288612.79 in Q4 2025 per IMTX's latest filing, from 52256762.58 in the prior quarter.
- Over five years, Cash from Operations peaked at 120527847.57 in Q1 2022 and troughed at 68288612.79 in Q4 2025.
- A 5-year average of 16828778.82 and a median of 30492948.76 in 2021 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations jumped 699.87% in 2022, then tumbled 397.17% in 2024.
- Over 5 years, Cash from Operations stood at 28900138.14 in 2021, then dropped by 11.02% to 32085759.39 in 2022, then soared by 365.17% to 85082100.18 in 2023, then sank by 173.44% to 62487184.62 in 2024, then dropped by 9.28% to 68288612.79 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 68288612.79, 52256762.58, and 44208685.61 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | -68.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -68.29 Mn |
| Dec 31, 2025 | -68.29 Mn |
| Sep 30, 2025 | -52.26 Mn |
| Sep 30, 2025 | -52.26 Mn |
| Jun 30, 2025 | -44.21 Mn |
| Jun 30, 2025 | -44.21 Mn |
| Mar 31, 2025 | -35.98 Mn |
| Mar 31, 2025 | -35.98 Mn |
| Dec 31, 2024 | -62.49 Mn |
| Dec 31, 2024 | -62.49 Mn |
| Sep 30, 2024 | -37.04 Mn |
| Sep 30, 2024 | -37.04 Mn |
| Jun 30, 2024 | -35.77 Mn |
| Jun 30, 2024 | -35.77 Mn |
| Mar 31, 2024 | -35.42 Mn |
| Mar 31, 2024 | -35.42 Mn |
| Dec 31, 2023 | 85.08 Mn |
| Dec 31, 2023 | 85.08 Mn |
| Sep 30, 2023 | -33.23 Mn |
| Sep 30, 2023 | -33.23 Mn |